-
Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, et al.
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus
Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced
Follicular Lymphoma. J Clin Oncol 2022.
-
Miyauchi E, Morita S, Nakamura A, Hosomi Y, et al.
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy
for Non-Small-Cell Lung Cancer With Mutated EGFR. J Clin Oncol 2022.
-
Arroyo N, Bell KJL, Hsiao V, Fernandes-Taylor S, et al.
Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of
Autopsy Studies. J Clin Endocrinol Metab 2022.
-
Lassman AB, Hoang-Xuan K, Polley MC, Brandes AA, et al.
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With
Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic
Oligodendroglial Tumors. J Clin Oncol 2022;40:2539-2545.
-
Mila-Aloma M, Ashton NJ, Shekari M, Salvado G, et al.
Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in
preclinical Alzheimer's disease. Nat Med 2022.
|